Skip to content
Nonprofiteer
← BECKMAN RESEARCH INSTITUTE

Form 990 for tax year 2023

Filed by BECKMAN RESEARCH INSTITUTE.

Totals

Total revenue
$285,315,317
Total expenses
$382,452,556
Contributions and grants received
$165,812,985
Grants paid
$1,633,728
Program service revenue
$19,939,417
Investment income
$83,859,993
Other revenue
$15,702,922
Total assets, end of year
$2,184,814,083
Total liabilities, end of year
$984,918,509
Net assets or fund balances, end of year
$1,199,895,574
Program services expenses (Part IX)
$324,818,769
Management and general expenses
$57,535,835
Fundraising expenses
$97,952
Program service expenses (Part III)
$324,818,769

Program services were 84.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1d · Related organizations

    $47,164,619

  • 1e · Government grants (contributions)

    $112,316,398

  • 1f · All other contributions, gifts and grants

    $6,331,968

  • 2a · Program service revenue: Research Activities

    total $18,765,463 · related or exempt $18,765,463

  • 2b · Program service revenue: Specialized Lab Revenue

    total $906,225 · related or exempt $906,225

  • 2c · Program service revenue: Graduate Education Program

    total $226,634 · related or exempt $226,634

  • 2d · Program service revenue: Rental Income - Graduate Education

    total $41,095 · related or exempt $41,095

  • 2f · All other program service revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 3 · Investment income

    total $16,232,828 · excluded $16,232,828

  • 5 · Royalties

    total $9,921,792 · excluded $9,921,792

  • 6c · Rental income or loss

    real property $0 · personal property $0

  • 7a · Gross sales of assets other than inventory

    securities $972,986,643

  • 7b · Less cost or other basis and sales expenses

    securities $905,359,478

  • 7c · Gain or loss

    securities $67,627,165 · other assets $0

  • 7d · Net gain or loss

    total $67,627,165 · excluded $67,627,165

  • 11a · Other revenue: INVESTMENT INCOME - SCHEDULES K-1

    total $5,781,130 · unrelated business $5,781,130

  • 11d · All other revenue

    total $0 · related or exempt $0 · unrelated business $0 · excluded $0

  • 11e · Other revenue, total

    $5,781,130

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $1,633,728 · program services $1,633,728

  • 4 · Benefits paid to or for members

    total $0 · program services $0

  • 5 · Compensation of officers, directors and key employees

    total $6,425,419 · program services $5,592,318 · management and general $830,426 · fundraising $2,675

  • 7 · Other salaries and wages

    total $169,475,979 · program services $147,502,217 · management and general $21,903,199 · fundraising $70,563

  • 8 · Pension plan contributions

    total $11,072,669 · program services $9,637,019 · management and general $1,431,040 · fundraising $4,610

  • 9 · Other employee benefits

    total $17,633,263 · program services $15,346,985 · management and general $2,278,936 · fundraising $7,342

  • 10 · Payroll taxes

    total $11,073,406 · program services $9,637,660 · management and general $1,431,135 · fundraising $4,611

  • 11b · Fees: legal

    total $4,825,897 · management and general $4,825,897

  • 11c · Fees: accounting

    total $217,974 · management and general $217,974

  • 11f · Fees: investment management

    total $2,240,568 · program services $1,753,837 · management and general $486,630 · fundraising $101

  • 11g · Fees: other

    total $22,012,938 · program services $21,180,114 · management and general $831,599 · fundraising $1,225

  • 12 · Advertising and promotion

    total $579,844 · program services $446,308 · management and general $133,508 · fundraising $28

  • 13 · Office expenses

    total $5,414,709 · program services $5,177,816 · management and general $236,827 · fundraising $66

  • 14 · Information technology

    total $11,238,343 · program services $8,796,799 · management and general $2,441,035 · fundraising $509

  • 15 · Royalties

    total $3,274,191 · program services $3,274,191

  • 16 · Occupancy

    total $12,465,042 · program services $9,594,420 · management and general $2,870,020 · fundraising $602

  • 17 · Travel

    total $2,023,113 · program services $1,557,203 · management and general $465,812 · fundraising $98

  • 19 · Conferences, conventions and meetings

    total $802,302 · program services $617,998 · management and general $184,265 · fundraising $39

  • 20 · Interest

    total $7,273,537 · program services $6,664,873 · management and general $608,664

  • 22 · Depreciation, depletion and amortization

    total $27,290,580 · program services $20,300,193 · management and general $6,986,961 · fundraising $3,426

  • 23 · Insurance

    total $273,935 · program services $210,850 · management and general $63,072 · fundraising $13

  • 24a · Other expenses: Lab/Medical Supplies & Equipment

    total $44,005,061 · program services $39,537,571 · management and general $4,466,462 · fundraising $1,028

  • 24b · Other expenses: Repairs & Maintenance

    total $6,441,052 · program services $4,972,396 · management and general $1,468,348 · fundraising $308

  • 24c · Other expenses: Grants Bad Debt Expenses

    total $5,367,343 · program services $4,131,278 · management and general $1,235,806 · fundraising $259

  • 24d · Other expenses: Taxes, Licenses, and Business Fees

    total $1,182,005 · program services $915,987 · management and general $265,962 · fundraising $56

  • 24e · All other expenses

    total $8,209,658 · program services $6,337,008 · management and general $1,872,257 · fundraising $393

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $60,820,327 · end of year $143,672,022

  • 2 · Savings and temporary cash investments

    beginning of year $17,954,726 · end of year $86,148,844

  • 3 · Pledges and grants receivable

    beginning of year $32,939,589 · end of year $29,548,450

  • 4 · Accounts receivable

    beginning of year $11,529,531 · end of year $8,599,072

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $5,021,682 · end of year $4,811,873

  • 9 · Prepaid expenses and deferred charges

    beginning of year $535,171 · end of year $529,677

  • 10a · Land, buildings and equipment: cost or other basis

    $604,377,873

  • 10b · Land, buildings and equipment: accumulated depreciation

    $332,289,562

  • 10c · Land, buildings and equipment, net

    beginning of year $287,026,896 · end of year $272,088,311

  • 11 · Investments: publicly traded securities

    beginning of year $292,147,105 · end of year $384,275,005

  • 12 · Investments: other securities

    beginning of year $1,050,475,531 · end of year $1,151,690,625

  • 13 · Investments: program-related

    beginning of year $0

  • 15 · Other assets

    beginning of year $188,020,216 · end of year $103,450,204

  • 17 · Accounts payable and accrued expenses

    beginning of year $41,235,914 · end of year $43,542,459

  • 19 · Deferred revenue

    beginning of year $15,776,874 · end of year $26,410,374

  • 20 · Tax-exempt bond liabilities

    beginning of year $49,451,350 · end of year $48,761,766

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $50,000,000 · end of year $50,000,000

  • 25 · Other liabilities

    beginning of year $672,030,774 · end of year $816,203,910

  • 27 · Net assets without donor restrictions

    beginning of year $1,087,515,597 · end of year $1,163,610,948

  • 28 · Net assets with donor restrictions

    beginning of year $30,460,265 · end of year $36,284,626

Mission and programs · 2023

Mission

THE SPECIFIC AND PRIMARY PURPOSE OF BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE IS TO DIRECTLY ENGAGE IN THE ACTIVE CONDUCT OF MEDICAL RESEARCH. PLEASE SEE SCHEDULE O FOR A CONTINUATION OF OUR MISSION.

Activities or mission (Part I)

TO DISCOVER AND TRANSLATE INNOVATIVE LABORATORY FINDINGS INTO NEW CLINICAL TREATMENTS BY USING PRACTICAL APPLICATIONS OF CHEMISTRY, PHYSICS AND BIOLOGY.

  • BIOMEDICAL RESEARCH AND DISEASE INVESTIGATIONS, INCLUDING DNA SYNTHESIS AND CELL ANALYSIS. BECKMAN RESEARCH INSTITUTE HAS PIONEERED SCIENTIFIC BREAKTHROUGHS RESULTING IN TREATMENTS THAT HAVE IMPROVED THE LIVES OF PATIENTS WORLDWIDE. NUMEROUS LIFE-SAVING DRUGS USE PATENTED TECHNOLOGY DEVELOPED AT BECKMAN RESEARCH INSTITUTE. THESE DRUGS INCLUDE SYNTHETIC HUMAN INSULIN (HUMULIN) FOR DIABETES, THE WIDELY USED CANCER DRUGS HERCEPTIN, RITUXAN AND AVASTIN, AND HUMIRA FOR ARTHRITIS. RESEARCHERS AT BECKMAN RESEARCH INSTITUTE UNDERTAKE FUNDAMENTAL INVESTIGATIONS IN DIABETES PROGRESSION AND TREATMENT, IMMUNOLOGY AND IMAGING, INTERFERING RNAS AND HIV TREATMENT, TOTAL SYNTHESIS OF COMPLEX AND THERAPEUTIC NATURAL PRODUCTS, MECHANISMS OF DRUG ACTION, NEUROGENESIS, STEM CELL THERAPY, DNA REPAIR AND RADIATION, AND THE IMMUNOBIOLOGY OF VIRAL INFECTION. THEY HAVE ACHIEVED MAJOR ADVANCES IN RECOMBINANT DNA TECHNOLOGY, MONOCLONAL ANTIBODIES, GENE THERAPY, EPIGENETICS, SI-RNA TECHNOLOGY AND CANCER IMMUNOTHERAPEUTICS. A DEPARTMENT IN BECKMAN RESEARCH INSTITUTE IS DEDICATED TO UNDERSTANDING AND DEVELOPING TREATMENTS BASED ON CANCER'S INTERACTION WITH THE IMMUNE SYSTEM. OTHER RESEARCH HAS IDENTIFIED PROTEINS THAT MAY PLAY CRITICAL ROLES IN IMMUNE RESPONSE AND MAY LEAD TO NEW TREATMENT STRATEGIES. ANOTHER MAJOR EMPHASIS FOR THE BECKMAN RESEARCH INSTITUTE SCIENTISTS IS PERSONALIZED RESEARCH AND MEDICINE -- ANALYZING A PATIENT'S UNIQUE GENETIC PROFILE TO DEVELOP TAILORED THERAPIES FOR THEIR SPECIFIC DISEASE. ALL OF THIS RESEARCH IS UNIQUELY SUPPORTED BY ONSITE MANUFACTURING FACILITIES THAT CAN TEST AND PRODUCE QUANTITIES OF CELL-BASED, GENE-BASED AND MOLECULAR THERAPIES. THESE FACILITIES FURTHER SERVE AS RESOURCES FOR MEDICAL AND SCIENTIFIC RESEARCH CENTERS NATIONWIDE. BECKMAN RESEARCH INSTITUTE SCIENTISTS SERVE AS FACULTY MEMBERS IN CITY OF HOPE'S IRELL & MANELLA GRADUATE SCHOOL OF BIOLOGICAL SCIENCES. THE GRADUATE SCHOOL'S MISSION IS TO TRAIN STUDENTS TO BE OUTSTANDING RESEARCH SCIENTISTS IN CHEMICAL, MOLECULAR AND CELLULAR BIOLOGY. THE SCHOOL IS ACCREDITED BY THE WESTERN ASSOCIATION OF SCHOOLS AND COLLEGES. GRADUATES OF THE PROGRAM, AWARDED A DOCTORATE OF PHILOSOPHY IN BIOLOGICAL SCIENCES, ARE EQUIPPED TO ADDRESS FUNDAMENTAL QUESTIONS IN LIFE SCIENCES AND BIOMEDICINE FOR CAREERS IN ACADEMIA, INDUSTRY AND GOVERNMENT.

    Expenses $324,818,769 · Grants $1,633,728 · Revenue $19,939,417

As filed on the 2023 return.

Listed in Part VII

  • Steven B Fink

    Director & Chair of the Board

    Total calculated
    $0
    Hours/week
    2 + 8 related
  • Charlotte Hubbert PhD

    Director

    Total calculated
    $0
    Hours/week
    2
  • Debbie C Thurmond

    Director/Professor

    Total calculated
    $457,019
    From this org
    $435,306
    From related orgs
    $0
    Other
    $21,713
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $398,867
    Bonus
    $13,599
    Other
    $22,840
    Deferred
    $0
    Nontaxable benefits
    $21,713
    Filer's total
    $457,019
  • Emmet Stephenson

    Director

    Total calculated
    $0
    Hours/week
    2
  • Julian Husbands MD

    Director

    Total calculated
    $0
    Hours/week
    2
  • Norman Payson MD

    Director

    Total calculated
    $0
    Hours/week
    2
  • Saro Armenian DO MPH

    Director/Professor

    Total calculated
    $0
    Hours/week
    2
  • Selwyn Isakow

    Director

    Total calculated
    $0
    Hours/week
    2 + 10 related
  • Stephanie Okey

    Director

    Total calculated
    $0
    Hours/week
    2 + 4 related
  • Todd M Binder

    Director

    Total calculated
    $0
    Hours/week
    2
  • Cristin J O'Callahan

    General Counsel & Corp Secretary

    Total calculated
    $1,472,464
    From this org
    $186,671
    From related orgs
    $944,668
    Other
    $341,125
    Hours/week
    10 + 51 related

    Schedule J breakdown matched by us

    Base
    $106,709 + $540,016 related
    Bonus
    $69,747 + $352,960 related
    Other
    $10,215 + $51,692 related
    Deferred
    $50,977 + $257,972 related
    Nontaxable benefits
    $5,309 + $26,867 related
    Filer's total
    $242,957 + $1,229,507 related
  • Donald J Matthewson

    Assistant Treasurer

    Total calculated
    $639,380
    From this org
    $125,464
    From related orgs
    $501,856
    Other
    $12,060
    Hours/week
    12 + 48 related

    Schedule J breakdown matched by us

    Base
    $81,226 + $324,904 related
    Bonus
    $33,946 + $135,784 related
    Other
    $10,292 + $41,168 related
    Deferred
    $1,999 + $7,996 related
    Nontaxable benefits
    $413 + $1,652 related
    Filer's total
    $127,876 + $511,504 related
  • Jo Ann Escasa-Haigh

    Chief Business Officer

    Total calculated
    $1,980,192
    From this org
    $365,936
    From related orgs
    $1,463,743
    Other
    $150,513
    Hours/week
    12 + 48 related

    Schedule J breakdown matched by us

    Base
    $192,096 + $768,383 related
    Bonus
    $169,340 + $677,360 related
    Other
    $4,500 + $18,000 related
    Deferred
    $24,552 + $98,207 related
    Nontaxable benefits
    $5,551 + $22,203 related
    Filer's total
    $396,039 + $1,584,153 related
  • Robert W Stone

    President & CEO

    Total calculated
    $6,149,982
    From this org
    $300,338
    From related orgs
    $4,182,312
    Other
    $1,667,332
    Hours/week
    4 + 56 related

    Schedule J breakdown matched by us

    Base
    $138,742 + $1,932,032 related
    Bonus
    $147,311 + $2,051,361 related
    Other
    $14,285 + $198,919 related
    Deferred
    $109,062 + $1,518,723 related
    Nontaxable benefits
    $2,650 + $36,897 related
    Filer's total
    $412,050 + $5,737,932 related
  • Yvette Tremonti

    Treasurer/Chief Financial Officer

    Total calculated
    $24,162
    From this org
    $0
    From related orgs
    $0
    Other
    $24,162
    Hours/week
    10 + 51 related
  • Ashley Baker Lee

    SVP, Research Operations

    Total calculated
    $1,222,938
    From this org
    $872,074
    From related orgs
    $218,018
    Other
    $132,846
    Hours/week
    48 + 12 related

    Schedule J breakdown matched by us

    Base
    $547,454 + $136,863 related
    Bonus
    $251,660 + $62,915 related
    Other
    $72,960 + $18,240 related
    Deferred
    $80,541 + $20,135 related
    Nontaxable benefits
    $25,736 + $6,434 related
    Filer's total
    $978,351 + $244,587 related
  • David A Horne

    Vice Prvst & Depty Dir BRI & Dn Fac Aff

    Total calculated
    $1,019,212
    From this org
    $914,413
    From related orgs
    $0
    Other
    $104,799
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $585,963
    Bonus
    $258,829
    Other
    $69,621
    Deferred
    $87,354
    Nontaxable benefits
    $17,445
    Filer's total
    $1,019,212
  • David Craig

    Dep Dir, Integr Transltnl Sci

    Total calculated
    $443,476
    From this org
    $428,774
    From related orgs
    $0
    Other
    $14,702
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $220,752
    Bonus
    $200,000
    Other
    $8,022
    Deferred
    $0
    Nontaxable benefits
    $14,702
    Filer's total
    $443,476
  • Debra F Fields

    Exec VP & Chief Transformation Ofc

    Total calculated
    $2,088,520
    From this org
    $340,881
    From related orgs
    $1,363,523
    Other
    $384,116
    Hours/week
    12 + 48 related

    Schedule J breakdown matched by us

    Base
    $184,215 + $736,861 related
    Bonus
    $136,114 + $544,454 related
    Other
    $20,552 + $82,208 related
    Deferred
    $69,330 + $277,318 related
    Nontaxable benefits
    $7,494 + $29,974 related
    Filer's total
    $417,705 + $1,670,815 related
  • John D Carpten

    Chf Sci Off, BRI Dir, Canc Ctr Dir

    Total calculated
    $1,139,917
    From this org
    $571,428
    From related orgs
    $467,532
    Other
    $100,957
    Hours/week
    33 + 27 related

    Schedule J breakdown matched by us

    Base
    $221,239 + $181,014 related
    Bonus
    $350,189 + $286,518 related
    Other
    $0
    Deferred
    $48,728 + $39,869 related
    Nontaxable benefits
    $6,798 + $5,562 related
    Filer's total
    $626,954 + $512,963 related
  • Marcellus R Van Den Brink MD PhD

    Pres COH LA & NMC & Chf Phys Exec

    Total calculated
    $1,155,272
    From this org
    $99,787
    From related orgs
    $898,082
    Other
    $157,403
    Hours/week
    6 + 54 related

    Schedule J breakdown matched by us

    Base
    $26,144 + $242,657 related
    Bonus
    $67,000 + $596,300 related
    Other
    $6,643 + $59,125 related
    Deferred
    $15,239 + $137,147 related
    Nontaxable benefits
    $502 + $4,515 related
    Filer's total
    $115,528 + $1,039,744 related
  • Mark Hulse

    Chief Digital Officer

    Total calculated
    $1,425,667
    From this org
    $276,672
    From related orgs
    $1,106,688
    Other
    $42,307
    Hours/week
    12 + 48 related

    Schedule J breakdown matched by us

    Base
    $159,761 + $639,043 related
    Bonus
    $100,658 + $402,634 related
    Other
    $16,253 + $65,011 related
    Deferred
    $5,318 + $21,274 related
    Nontaxable benefits
    $3,143 + $12,572 related
    Filer's total
    $285,133 + $1,140,534 related
  • Steven Terry Rosen MD

    EVP, Dir Emeritus Comp Canc Ctr & BRI

    Total calculated
    $2,042,368
    From this org
    $1,562,947
    From related orgs
    $173,661
    Other
    $305,760
    Hours/week
    54 + 6 related

    Schedule J breakdown matched by us

    Base
    $850,948 + $94,550 related
    Bonus
    $602,590 + $66,954 related
    Other
    $109,409 + $12,157 related
    Deferred
    $260,143 + $28,905 related
    Nontaxable benefits
    $15,041 + $1,671 related
    Filer's total
    $1,838,131 + $204,237 related
  • Edward S Kim

    Director, System Clin Trials

    Total calculated
    $1,722,035
    From this org
    $396,461
    From related orgs
    $1,189,384
    Other
    $136,190
    Hours/week
    15 + 47 related

    Schedule J breakdown matched by us

    Base
    $223,878 + $671,636 related
    Bonus
    $106,430 + $319,290 related
    Other
    $66,153 + $198,458 related
    Deferred
    $28,178 + $84,533 related
    Nontaxable benefits
    $5,870 + $17,609 related
    Filer's total
    $430,509 + $1,291,526 related
  • Harlan Alcon Levine

    Pres, Hlth Innovation & Policy

    Total calculated
    $2,392,717
    From this org
    $364,681
    From related orgs
    $1,624,490
    Other
    $403,546
    Hours/week
    11 + 49 related

    Schedule J breakdown matched by us

    Base
    $195,927 + $872,767 related
    Bonus
    $149,177 + $664,517 related
    Other
    $19,577 + $87,206 related
    Deferred
    $66,072 + $294,321 related
    Nontaxable benefits
    $7,911 + $35,242 related
    Filer's total
    $438,664 + $1,954,053 related
  • Kristin Bertell

    Chief Philanthropy Officer

    Total calculated
    $1,558,973
    From this org
    $41,469
    From related orgs
    $1,202,603
    Other
    $314,901
    Hours/week
    2 + 58 related

    Schedule J breakdown matched by us

    Base
    $21,849 + $633,610 related
    Bonus
    $17,257 + $500,460 related
    Other
    $2,363 + $68,533 related
    Deferred
    $9,214 + $267,194 related
    Nontaxable benefits
    $1,283 + $37,210 related
    Filer's total
    $51,966 + $1,507,007 related
  • Larry Kwak

    Deputy Dir, Comp Cancer Ctr

    Total calculated
    $1,092,000
    From this org
    $1,040,975
    From related orgs
    $0
    Other
    $51,025
    Hours/week
    60

    Schedule J breakdown matched by us

    Base
    $767,345
    Bonus
    $185,418
    Other
    $88,212
    Deferred
    $26,592
    Nontaxable benefits
    $24,433
    Filer's total
    $1,092,000
  • Vijay Trisal MD

    System Chief Clinical Officer

    Total calculated
    $1,259,854
    From this org
    $37,057
    From related orgs
    $1,074,649
    Other
    $148,148
    Hours/week
    2 + 58 related

    Schedule J breakdown matched by us

    Base
    $24,176 + $701,101 related
    Bonus
    $10,201 + $295,833 related
    Other
    $2,680 + $77,715 related
    Deferred
    $3,751 + $108,780 related
    Nontaxable benefits
    $1,187 + $34,430 related
    Filer's total
    $41,995 + $1,217,859 related
  • Jennifer Parkhurst

    Former Officer

    Total calculated
    $1,629,131
    From this org
    $312,857
    From related orgs
    $1,251,429
    Other
    $64,845
    Hours/week
    12 + 48 related

    Schedule J breakdown matched by us

    Base
    $136,392 + $545,569 related
    Bonus
    $80,007 + $320,027 related
    Other
    $96,458 + $385,833 related
    Deferred
    $5,018 + $20,073 related
    Nontaxable benefits
    $7,951 + $31,803 related
    Filer's total
    $325,826 + $1,303,305 related
  • Philip Okala

    FORMER OFFICER

    Total calculated
    $892,045
    From this org
    $175,540
    From related orgs
    $702,160
    Other
    $14,345
    Hours/week
    12 + 48 related

    Schedule J breakdown matched by us

    Base
    $137,410 + $549,640 related
    Bonus
    $0
    Other
    $38,130 + $152,520 related
    Deferred
    $0
    Nontaxable benefits
    $2,869 + $11,476 related
    Filer's total
    $178,409 + $713,636 related

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · First-class or charter travel
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4b · Supplemental nonqualified retirement plan
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

Schedule J, Part I, Line 1a First-class or charter travel
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE PERMITS FIRST CLASS TRAVEL FOR CERTAIN OFFICERS, DIRECTORS, AND KEY EXECUTIVES IN LIMITED CIRCUMSTANCES WHEN SPECIFIED TRAVEL CRITERIA ARE MET.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
CITY OF HOPE HAS A NON QUALIFIED SECTION 457(F) EXECUTIVE SUPPLEMENTAL ACCUMULATION PLAN THAT IS DESIGNED AND MAINTAINED TO PROVIDE A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES WITH DEFERRED COMPENSATION. THE PLAN VESTS AFTER THREE (3) FISCAL YEARS OF SERVICE AND THE VESTED TOTALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (B) (III). PRIOR TO VESTING, THE ANNUAL CONTRIBUTION AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (C). PURSUANT TO THE PLAN DOCUMENT, VESTED PARTICIPANTS ARE ENTITLED TO WITHDRAW FROM THEIR VESTED ACCOUNT AN AMOUNT EQUAL TO THE FEDERAL, STATE, LOCAL AND FICA TAXES THEY OWE. THESE AMOUNTS ARE REMITTED TO THE APPROPRIATE TAXING AUTHORITIES ON BEHALF OF THE PARTICIPANTS. FOR CALENDAR YEAR 2023, THE FOLLOWING INDIVIDUALS WITHDREW THE REFERENCED AMOUNTS TO COVER SUCH TAXES: ASHLEY BAKER LEE - $19,924 DEBRA FIELDS - $35,501 DAVID HORNE - $17,616 MARK HULSE - $28,478 EDWARD KIM - $84,759 DONALD MATTHEWSON - $10,014 STEVEN TERRY ROSEN - $34,090 ROBERT STONE - $59,965 VIJAY TRISAL - $17,540
Schedule J, Part I, Line 7 Non-fixed payments
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE'S EXECUTIVES AND CERTAIN KEY EMPLOYEES ARE ELIGIBLE TO RECEIVE INCENTIVE COMPENSATION UNDER AN ANNUAL INCENTIVE PLAN (AIP) TIED TO ORGANIZATIONAL KEY PERFORMANCE INDICATORS AND INDIVIDUAL OBJECTIVES. THE KEY PERFORMANCE INDICATORS REFLECT KEY AREAS OF STRATEGIC FOCUS AND THE EXEMPT HEALTHCARE MISSION OF CITY OF HOPE AND AFFILIATES AND ARE BOTH FINANCIAL AND NON-FINANCIAL. THE POTENTIAL INCENTIVE COMPENSATION IS BASED ON A WEIGHTED AVERAGE AMONG ALL INDICATORS AND IS PAID AS A PERCENTAGE OF EACH INDIVIDUAL PARTICIPANT'S BASE COMPENSATION. THE KEY PERFORMANCE INDICATORS ARE WEIGHTED BASED ON THE PARTICIPANT'S PRIMARY AREA(S) OF RESPONSIBILITY, WITH ORGANIZATIONAL KEY PERFORMANCE INDICATORS WEIGHTED FROM 70 PERCENT TO 90 PERCENT, AND THE INDIVIDUAL OBJECTIVES WEIGHTED FROM 10 PERCENT TO 30 PERCENT. THE AIP IS UNDER THE CONTROL OF, AND ADMINISTERED BY, THE INDEPENDENT DIRECTORS SERVING ON THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE. TO BE ELIGIBLE, THE PARTICIPANTS IN THE AIP MUST BE EMPLOYED BY CITY OF HOPE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. CITY OF HOPE MAY, IN ITS DISCRETION, CANCEL ALL OR A PORTION OF ANY INCENTIVE PLAN PAYMENT OR AWARD TO ANY PARTICIPANT, WHETHER BEFORE OR FOLLOWING PAYMENT OF SUCH AWARD, SUBJECT TO COMPLIANCE WITH APPLICABLE LAW, UNDER THE FOLLOWING CIRCUMSTANCES (CANCELLATION POLICY): A) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY RESTATES OR OTHERWISE ADJUSTS THE ANNUAL PERFORMANCE MEASUREMENT CALCULATION IN A MANNER THAT WOULD REDUCE THE SIZE OF THE AWARD OR PAYMENT, OR; B) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY DETERMINES THAT ONE OF MORE OF THE ANNUAL PERFORMANCE MEASUREMENT CALCULATIONS ON WHICH THE AWARD IS BASED OR IS PAID ARE MATERIALLY INACCURATE. THE AIP INCENTIVE COMPENSATION EARNED FOR FISCAL YEAR 2023 WAS PAID IN CALENDAR YEAR 2023 AND THESE AMOUNTS HAVE BEEN REPORTED IN SCHEDULE J, PART II, COLUMN (B)(II). ADDITIONALLY, BECKMAN RESEARCH INSTITUTE HAS AN EXECUTIVE LONG-TERM INCENTIVE (LTI) PLAN FOR CERTAIN EXECUTIVES WHICH IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM FOR ACHIEVING KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE PLAN ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE PERFORMANCE PERIOD OF THE PLAN (CYCLE 9) RAN FROM OCTOBER 1, 2020 THROUGH SEPTEMBER 30, 2023 WITH A NEW THREE-YEAR PERFORMANCE PERIOD BEGINNING EACH OCTOBER 1ST THEREAFTER (E.G., CYCLE 10 RUNS FROM OCTOBER 1, 2021 THROUGH SEPTEMBER 30, 2024). TO BE ELIGIBLE TO PARTICIPATE IN ANY PAYOUT UNDER THE PLAN, PARTICIPANTS MUST BE ACTIVELY EMPLOYED BY BECKMAN RESEARCH INSTITUTE AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. WHILE THE PLAN DOES MEET THE REQUIREMENTS FOR A SUBSTANTIAL RISK OF FORFEITURE, AS OF THE CALENDAR YEAR ENDING DECEMBER 31, 2023, THE POTENTIAL LTI AMOUNTS HAVE BEEN ESTIMATED AND ACCRUED DURING THE CURRENT TAX YEAR AND ARE REPORTED AS DEFERRED COMPENSATION TO THE PLAN PARTICIPANTS IN SCHEDULE J, PART II, COLUMN (C). THE LTI PLAN IS SUBJECT TO THE SAME CANCELLATION POLICY AS THE AIP DESCRIBED PREVIOUSLY. PARTICIPANTS WHO MET THE ELIGIBILITY CRITERIA RECEIVED A PAYOUT OF PLAN CYCLE 9 LTI INCENTIVES (OCTOBER 1, 2020 THROUGH SEPTEMBER 30, 2023) IN DECEMBER 2023. THESE AMOUNTS HAVE BEEN REFLECTED IN SCHEDULE J, PART II, COLUMN (B)(II).
Schedule J, Part II Employees serving as members of the board of directors
DEBBIE THURMOND, PH.D., IS MEMBER OF THE BECKMAN RESEARCH INSTITUTE'S BOARD OF DIRECTORS IN ADDITION TO BEING AN EMPLOYEE OF BECKMAN RESEARCH INSTITUTE. DR. THURMOND IS THE DIRECTOR OF THE ARTHUR RIGGS DIABETES & METABOLISM RESEARCH INSTITUTE AND A RENOWNED RESEARCH SCIENTIST, PROFESSOR AND THE FOUNDING CHAIR OF THE DEPARTMENT OF MOLECULAR AND CELLULAR ENDOCRINOLOGY. NONE OF THESE INDIVIDUALS WERE COMPENSATED FOR THEIR SERVICES AS MEMBERS OF THE BECKMAN RESEARCH INSTITUTE'S BOARD OF DIRECTORS. COMPENSATION EARNED BY THOSE INDIVIDUALS EMPLOYED BY BECKMAN RESEARCH INSTITUTE IS REPORTED ON FORM 990, PART VII, SECTION A AND SUBSEQUENTLY ON SCHEDULE J, PART II.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related partnerships

Part III: related organizations taxable as a partnership, with the filer's share.

  • AccessHope LLC

    N/A · Oncology Support · DE

    Directly controlled by NA

  • Southern California Radiation Oncology LLC

    N/A · Radiation Oncology · DE

    Directly controlled by NA

Provenance

Return type
form_990
Tax year
2023
Filed
13 August 2025
IRS schema version
2023v6.0
Source object
202512259349301831

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.